Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells.

Subjects

Subjects :

*DRUG interactions
*CERAMIDES
*DOXORUBICIN
*TRIPLE-negative breast cancer
*CANCER stem cells

Details

Language :

English

ISSN :

09396411

Volume :

172

Database :

Academic Search Index

Journal :

European Journal of Pharmaceutics & Biopharmaceutics

Publication Type :

Academic Journal

Accession number :

155658398

Full Text :

https://doi.org/10.1016/j.ejpb.2022.01.006